US2020138883A1PendingUtilityA1
Pharmaceutical composition for prevention or treatment of gynecological diseases containing extract of sarcodon imbricatus as active ingredient
Est. expiryMar 23, 2037(~10.7 yrs left)· nominal 20-yr term from priority
A23V 2250/208A61K 9/0056A23V 2002/00A23L 33/10A61K 2236/333A23V 2200/30A61P 15/08A23L 31/15A61K 36/07A61P 29/00A61P 15/00A61K 2236/53A61K 2236/51A61K 2236/39A61K 2236/331A23L 33/105A61K 33/30A61K 33/26A61K 33/14A61K 33/10A61K 33/06A61K 31/714A61K 31/525A61K 31/519A61K 31/51A61K 31/4415A61K 31/4188A61K 31/375A61K 31/355A61K 31/197A61K 31/07Y02A50/30
48
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The present invention relates to a composition for prevention or treatment of gynecological diseases containing an extract of Sarcodon imbricatus as an active ingredient. Specifically, the extract of Sarcodon imbricatus of the present invention can be effectively used, with only one dose, for prevention or treatment of gynecological diseases by treating dysmenorrhea, reducing a menstrual period, an amount of menstruation, menstrual irregularity, and extravasated blood, and clearing the color of menstruation.
Claims
exact text as granted — not AI-modified1 . A pharmaceutical composition for preventing or treating gynecological diseases, the pharmaceutical composition comprising:
Sarcodon aspratus extracts as active ingredients.
2 . The pharmaceutical composition according to claim 1 , wherein the Sarcodon aspratus extracts are obtained from fruit bodies of Sarcodon aspratus.
3 . The pharmaceutical composition according to claim 1 , wherein the Sarcodon aspratus extracts are extracted using water, an alcohol having C 1 to C 4 , or a mixture thereof as a solvent.
4 . The pharmaceutical composition according to claim 3 , wherein the alcohol having C 1 to C 4 is methanol or ethanol.
5 . The pharmaceutical composition according to claim 1 , wherein the gynecological diseases are diseases caused by an imbalance of female hormones.
6 . The pharmaceutical composition according to claim 1 , wherein the gynecological diseases are one or more selected from the group consisting of dysmenorrhea, premenstrual syndrome, edema, menstrual irregularity, leukorrhea, extravasated blood, cold hands/feet syndrome, lower back pain, skin trouble, insomnia, alopecia, depression, dizziness, headache, constipation, diarrhea, hot flush, tinnitus, and urinary frequency, which are caused by an imbalance of female hormones.
7 . A functional health food for preventing or treating gynecological diseases, the functional health food comprising:
Sarcodon aspratus extracts as active ingredients.
8 . The functional health food according to claim 7 , wherein the Sarcodon aspratus extracts are obtained from fruit bodies of Sarcodon aspratus.
9 . The functional health food according to claim 7 , wherein the gynecological diseases are diseases caused by an imbalance of female hormones.
10 . The functional health food according to claim 7 , wherein the gynecological diseases are one or more selected from the group consisting of dysmenorrhea, premenstrual syndrome, edema, menstrual irregularity, leukorrhea, extravasated blood, cold hands/feet syndrome, lower back pain, skin trouble, insomnia, alopecia, depression, dizziness, headache, constipation, diarrhea, hot flush, tinnitus, and urinary frequency, which are caused by an imbalance of female hormones.
11 . A method of preventing or treating gynecological diseases, the method comprising:
a step of administering Sarcodon aspratus extracts to a subject.
12 . A use of Sarcodon aspratus extracts for preparation of a pharmaceutical composition for preventing or treating gynecological diseases.Join the waitlist — get patent alerts
Track US2020138883A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.